Wegovy is now a tablet as well as an injection, and the tablet self-pays cheaper. Novo's published prices are $149 a month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg and 25 mg, against $349 a month for the pen at any standard dose.1
One of those numbers is changing this week, and Novo's own two pages do not currently agree about it.
The 4 mg price moves on 31 August
Read on 27 August 2026, the NovoCare Pharmacy page says:1
Patients pay $149 for each month of 1.5 mg, $199 per month for 4 mg and $299 per month for 9 mg and 25 mg.
NovoCare Pharmacy
And on the same day, Novo's Wegovy savings page says:2
Patients pay $149 for each month of 1.5 mg and 4 mg. 4 mg offer only available until August 31, 2026, then $199 per month for 4 mg.
NovoCare, Wegovy savings offer
Both of those are live right now. The savings page still shows 4 mg at $149 with a deadline; the pharmacy page has already moved it to $199. If you are on or heading for the 4 mg dose, that is a $50 a month difference and a few days to sort it out. Confirm the figure at checkout rather than from any article, this one included.
We are not going to tell you which page is operative, because we do not know and guessing would be worse than saying so. What we can tell you is the date, that it is days away, and that it applies to one specific strength.
The pill against the pen
For a cash buyer this is the comparison that matters, and it does not go the way most people assume:
| Wegovy, self-pay | Price |
|---|---|
| Tablet, 1.5 mg | $149/mo |
| Tablet, 4 mg | $149/mo until 31 Aug, then $199/mo |
| Tablet, 9 mg and 25 mg | $299/mo |
| Pen, 0.25 to 2.4 mg | $349/mo |
| Pen HD, 7.2 mg | $399/mo |
All quoted from Novo's own pages.12 The entry tablet is well under half the pen. Whether a tablet or an injection is right for you is a clinical question and not one a price table answers, but the money is not the reason to choose the pen. The pen ladder is here.
There are three semaglutide pills now, and they are not the same
This is the part almost every page about "Wegovy weight loss pills" has not caught up with. Per the FDA's own National Drug Code directory:3
| Pill | Strengths | On sale since | Approved for |
|---|---|---|---|
| Rybelsus | 3, 7, 14 mg | September 2019 | Type 2 diabetes |
| Wegovy pill | 1.5, 4, 9, 25 mg | January 2026 | Obesity |
| Ozempic pill | 1.5, 4, 9 mg | April 2026 | Type 2 diabetes |
If you searched for a semaglutide pill and landed on a page about Rybelsus, you were reading about a different product at different strengths approved for something else. Rybelsus is the 2019 one. The Wegovy pill is the one indicated for weight.
Worth knowing: Novo's own cash pharmacy sells the Wegovy pill and the Ozempic pill and does not list Rybelsus at all.
What the sellers we track charge
Novo is not the only route to an oral semaglutide, and the ranking is closer than the brand-versus-compounded gap usually is:
Read that with the $149 in mind. On today's board, the branded Wegovy pill bought directly from Novo costs less than the same branded pill bought through most of the telehealth programs that resell it, once their membership fees are counted. We would rather point that out than not.
What to actually do about the deadline
Three practical things, none of which requires taking our word for anything:
- If you are at 4 mg, check what you are actually charged this cycle, and again in September.
- If you are choosing a dose with a prescriber, the pricing steps are not evenly spaced: 1.5 mg and 4 mg sit together, then 9 mg and 25 mg jump to $299. That is worth knowing, though it is obviously not a reason to pick a dose.
- If you want to be told when this moves, that is what the alert is for. We re-check these numbers weekly and this one has a date on it.